OMID
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
N/A
58 days until earnings call
ROMJF
Price
$0.34
Change
+$0.01 (+3.03%)
Updated
Jul 3 closing price
Capitalization
19.9M
Interact to see
Advertisement

OMID vs ROMJF

Header iconOMID vs ROMJF Comparison
Open Charts OMID vs ROMJFBanner chart's image
Omid
Price$0.02
Change-$0.00 (-0.00%)
Volume$900
CapitalizationN/A
Rubicon Organics
Price$0.34
Change+$0.01 (+3.03%)
Volume$12.2K
Capitalization19.9M
OMID vs ROMJF Comparison Chart in %
Loading...
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMID vs. ROMJF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMID is a Hold and ROMJF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (OMID: $0.02 vs. ROMJF: $0.34)
Brand notoriety: OMID and ROMJF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OMID: 2% vs. ROMJF: 65%
Market capitalization -- OMID: $0 vs. ROMJF: $19.9M
OMID [@Pharmaceuticals: Other] is valued at $0. ROMJF’s [@Pharmaceuticals: Other] market capitalization is $19.9M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMID’s FA Score shows that 1 FA rating(s) are green whileROMJF’s FA Score has 0 green FA rating(s).

  • OMID’s FA Score: 1 green, 4 red.
  • ROMJF’s FA Score: 0 green, 5 red.
According to our system of comparison, ROMJF is a better buy in the long-term than OMID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMID’s TA Score shows that 5 TA indicator(s) are bullish while ROMJF’s TA Score has 4 bullish TA indicator(s).

  • OMID’s TA Score: 5 bullish, 3 bearish.
  • ROMJF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OMID is a better buy in the short-term than ROMJF.

Price Growth

OMID (@Pharmaceuticals: Other) experienced а +2.86% price change this week, while ROMJF (@Pharmaceuticals: Other) price change was +9.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

OMID is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROMJF YTD gains are higher at: 3.912 vs. OMID (-8.861).
OMIDROMJFOMID / ROMJF
CapitalizationN/A19.9M-
EBITDAN/A1.21M-
Gain YTD-8.8613.912-227%
P/E RatioN/AN/A-
RevenueN/A39.2M-
Total CashN/A7.6M-
Total DebtN/A10.4M-
FUNDAMENTALS RATINGS
OMID vs ROMJF: Fundamental Ratings
OMID
ROMJF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
191
PRICE GROWTH RATING
1..100
8256
P/E GROWTH RATING
1..100
71100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ROMJF's Valuation (42) in the null industry is somewhat better than the same rating for OMID (78). This means that ROMJF’s stock grew somewhat faster than OMID’s over the last 12 months.

OMID's Profit vs Risk Rating (91) in the null industry is in the same range as ROMJF (100). This means that OMID’s stock grew similarly to ROMJF’s over the last 12 months.

OMID's SMR Rating (1) in the null industry is significantly better than the same rating for ROMJF (91). This means that OMID’s stock grew significantly faster than ROMJF’s over the last 12 months.

ROMJF's Price Growth Rating (56) in the null industry is in the same range as OMID (82). This means that ROMJF’s stock grew similarly to OMID’s over the last 12 months.

OMID's P/E Growth Rating (71) in the null industry is in the same range as ROMJF (100). This means that OMID’s stock grew similarly to ROMJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMIDROMJF
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
67%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEHR15.600.47
+3.11%
Aehr Test Systems
IMCR33.020.27
+0.82%
Immunocore Holdings plc
MATH3.550.01
+0.28%
Metalpha Technology Holding Limited
FTAIN25.40N/A
N/A
FTAI Aviation Ltd
NNN43.51-0.17
-0.39%
NNN Reit

OMID and

Correlation & Price change

A.I.dvisor tells us that OMID and EOLS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMID and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMID
1D Price
Change %
OMID100%
N/A
EOLS - OMID
22%
Poorly correlated
+0.65%
OILFF - OMID
8%
Poorly correlated
+3.58%
PHCUF - OMID
5%
Poorly correlated
N/A
ROMJF - OMID
2%
Poorly correlated
+4.20%
OASMY - OMID
2%
Poorly correlated
N/A
More

ROMJF and

Correlation & Price change

A.I.dvisor tells us that ROMJF and PHCUF have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMJF and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROMJF
1D Price
Change %
ROMJF100%
+4.20%
PHCUF - ROMJF
13%
Poorly correlated
N/A
PCLOF - ROMJF
8%
Poorly correlated
+37.05%
SGIOF - ROMJF
8%
Poorly correlated
N/A
SGIOY - ROMJF
8%
Poorly correlated
-2.15%
RSCI - ROMJF
5%
Poorly correlated
N/A
More